Cancer risk in users of calcium channel blockers
Vermes, I.; Haanen, C.; Fox, C.; Reutelingsperger, C.
Hypertension 30(6): 1641-1642
1997
ISSN/ISBN: 0194-911X PMID: 9403598 Document Number: 474006
Document emailed within 1 workday
Related Documents
Held, P.H.; Yusuf, S. 1993: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction European Heart Journal 14(Suppl): 18-25Chourashy, B.K. 1988: Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates Journal of the Indian Medical Association 86(10): 274-276
Sokrut, V.N.; Iabluchanskiĭ, N.I.; Pavlenko, L.A. 1992: Calcium and calcium-channel blockers in the healing of an experimental myocardial infarct Eksperimental'naia i Klinicheskaia Farmakologiia 55(2): 20-23
Smeland, E.; Bremnes, R.M.; Fuskevag, O.M.; Aarbakke, J. 1995: The effect of calcium channel blockers and calcium on methotrexate accumulation in rat hepatocytes Anticancer Research 15(4): 1221-1225
Kuwahara, T.; Kawai, C.; Matsunaga, M. 1985: Pharmacology of calcium channel blockers Nihon Rinsho. Japanese Journal of Clinical Medicine 43(5): 978-982
Stone, K.S.; Scordo, K.A. 1984: Understanding the calcium channel blockers Heart and Lung: the Journal of Critical Care 13(5): 563-573
Das, G. 1988: Fundamentals of calcium channel blockers International Journal of Clinical Pharmacology Therapy and Toxicology 26(12): 575-584
Melena, J.; Osborne, N.N. 2000: Use of calcium channel blockers in glaucoma Archivos de la Sociedad Espanola de Oftalmologia 75(1): 3-4
Kimura, M.; Kimura, I.; Kondoh, T.; Tsuneki, H. 1991: Noncontractile acetylcholine receptor-operated Ca++ mobilization: suppression of activation by open channel blockers and acceleration of desensitization by closed channel blockers in mouse diaphragm muscle Journal of Pharmacology and Experimental Therapeutics 256(1): 18-23
Montastruc, J.L.; Senard, J.M. 1992: Calcium channel blockers and prevention of migraine Pathologie-Biologie 40(4): 381-388
Capparelli, E.V. 1992: New calcium-channel blockers: improved therapy? Clinical Pharmacy 11(6): 549-552
Raspa, R.F.; Wilson, C.C. 1993: Calcium channel blockers in the treatment of hypertension American Family Physician 48(3): 461-470
Biswas, T.K. 2003: Endothelium, atherosclerosis and calcium channel blockers Journal of the Indian Medical Association 101(7): 428-431
Godfraind, T. 1998: Tissue selectivity of calcium channel blockers Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 192(1): 121-135
Rego, E.M.; Corrado, A.P.; Prado, W.A. 1990: Antinociceptive effects of calcium channel blockers in the rat Brazilian Journal of Medical and Biological Research 23(3-4): 297-305
Smith, G.N. 1996: Calcium channel blockers and myocardial infarction Journal of Family Practice 42(1): 30-32
Chitwood, K.K.; Heim-Duthoy, K.L. 1993: Immunosuppressive properties of calcium channel blockers PharmacoTherapy 13(5): 447-454
Bonn, D. 2004: Schistosomiasis: a new target for calcium channel blockers LANCET. Infectious Diseases 4(4): 190
Wasek, Z. 1988: Calcium channel blockers and their value in the treatment of bronchial asthma Pneumonologia Polska 56(10): 467-471
Mackay, J.A.; Sever, P.S. 1996: Calcium channel blockers in the dock: innocent or guilty? Journal of Human Hypertension 10(5): 277-280